| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Maxcyte, Inc.
13D
MXCT · 57777K106
|
4.9% |
11/2/2026
Event 10/30/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.